0R15 8884.0068 1.4156% 0R1E 9171.0 0.0% 0M69 None None% 0R2V 255.5 0.3929% 0QYR 1619.0 0.0% 0QYP 434.5 -0.344% 0RUK None None% 0RYA 1600.0 4.5752% 0RIH 195.2 1.3763% 0RIH 195.2 1.3763% 0R1O 225.5 9877.8761% 0R1O None None% 0QFP None None% 0M2Z 255.0 0.2457% 0VSO 33.3 -6.4738% 0R1I None None% 0QZI 596.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 236.3943 1.5483%
Symbol | Company Name | GICS Sector Name | Market Cap (GBP Millions) | CMP | Closing Market Price (GBX) | % Change | Consensus Target Price(GBX) | Consensus Recommendation | EPS/Price growth > 10% | Current Debt | 3 years back debt | Current Operating Cash Flow" | No of Analyst - Strong Buy | No of Analyst - Buy | No of Analyst - Hold | No of Analyst -Sell | No of Analyst -Strong Sell | Revenue Estimate - FY1 (in million GBP) | Revenue Estimate - FY2 (in million GBP) | Revenue Estimate - FY3 (in million GBP) | EPS Estimate - FY1 (in GBP) | EPS Estimate - FY2 (in GBP) | EPS Estimate - FY3 (in GBP) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subscribe to get access of screener
@ GBP 299/Month
Source: Data Powered by Licensed Source, Data as of Dec. 12, 2024. The above companies data is updated on a weekly basis.
Note: 1Y = 1 Year; 3Y = 3 Years; 5Y = 5 Years; ROE refers to return on equity; ROIC refers to return on invested capital; PE refers to price to earnings ratio; TTM refers to Trailing Twelve Months; LFY refers to last fiscal year; EPS refers to Basic Earnings per Share; P/E refers to Price to Earnings Ratio; SMA refers to simple moving average; CMP refers to Current Market Price; WACC refers to Weighted Average Cost of Capital; LTM refers to Last Twelve Months; D/E refers Debt to Equity Ratio; Current Asset metrics for 'Banks' refer to end of period (EOP) loans divided by end of period (EOP) deposits; NA refers to data not available
^Broker estimates for upcoming fiscal year
Source: Data Powered by Licensed Source, Data as of Dec. 12, 2024. *The above performance data is based on average price change for selected stocks listed on NASDAQ, as per the screening criterias defined for Low Debt High Cash Stocks. The performance data is updated on a weekly basis.
The Low Debt High Cash Stocks Screener is designed to identify financially strong companies that prioritize reducing debt while increasing cash flow and profitability. These companies demonstrate prudent financial management, characterized by a decline in debt levels, growth in operating cash flows, and strong earnings performance relative to their stock price. Such companies are typically more resilient during economic downturns and have the flexibility to reinvest in growth opportunities or return capital to shareholders.
This screener is ideal for investors seeking companies with strong financial discipline, evidenced by reducing debt, increasing cash flow, and delivering solid earnings growth relative to their stock price. These companies offer both stability and growth potential.
Key Metrics Overview
Key Metrics |
Description |
Last Reported Debt (Annual) |
This metric reflects the company’s most recently reported total debt. |
Last Year Operating Cash Flow |
Operating cash flow represents the cash generated from a company’s core business operations. |
5 Year Growth in EPS/Price |
This metric measures the growth in earnings per share (EPS) relative to the stock price over the past five years. |
Disclaimer - kalkine.co.uk and associated pages are published by Kalkine Limited, company number 0790332 (FCA Firm Reference Number 579414). The information on this website has been prepared from a wide variety of sources, which Kalkine Limited, to the best of its knowledge and belief, considers accurate. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website. The advice given by Kalkine Limited and provided on this website is general information/ non-personalised advice only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. You should make your own enquiries about any investments, and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Limited has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. Please note past performance is neither an indicator nor a guarantee of future performance. To the extent permitted by law, Kalkine Limited excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Limited hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them.
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!